Adlac Life Science Private Limited
About Adlac Life Science Private Limited
Data last updated:
Adlac Life Science Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2007PTC051082. Its GSTIN is 24AAGCA4913R1ZD (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rupesh Dipakbhai Shah and Meet Rupeshbhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalol, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.94 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹55,444 (net margin -0.3%) and EBITDA of ₹6,154 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adlac Life Science Private Limited's registered office is in Kalol, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address817 Kothari Industrial Estate, Kothari Cross Road, Kalol, Gujarat, India – 382721
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adlac Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adlac Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adlac Life Science Private Limited, buy the company report.
Financials of Adlac Life Science Private Limited
FY 2025 filings availableAdlac Life Science Private Limited reported revenue of ₹1.94 Cr (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,154 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹55,444 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adlac Life Science Private Limited, buy the company report.
Board of directors of Adlac Life Science Private Limited
Adlac Life Science has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupesh Dipakbhai Shah Also directs: Om Laboratories India Private Limited | Director | 11 Jun 2007 | 19 Years 4 Months | Current |
| Meet Rupeshbhai Shah Also directs: Om Laboratories India Private Limited | Director | 17 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Adlac Life Science Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glynis Pharmaceutical Private Limited | ₹1.95 Cr (FY 2021) | 264.0% | Ranaghat, West Bengal, India | |||
| Adlac Life Science Private Limitedthis company | ₹1.94 Cr (FY 2025) | -₹55,444 | -0.3% | -21.0% | Kalol, Gujarat, India | |
| MP Laboratories Private Limited | ₹1.93 Cr (FY 2024) | 26.0% | Chennai, Tamil Nadu, India | |||
| Medo Specia Pharma Private Limited | ₹1.92 Cr (FY 2021) | -50.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Adlac Life Science Private Limited, buy the company report.
Auditor
Adlac Life Science Private Limited is audited by PARESH THOTHAWALA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARESH THOTHAWALA & CO | FY 2020 | 114777W |
Shareholding
The shareholding of Adlac Life Science Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Adlac Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adlac Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adlac Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adlac Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCA4913R1ZD | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adlac Life Science Private Limited, buy the company report.
Recent activity
Adlac Life Science Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Meet Rupeshbhai Shah ceased to be Additional Director on 25 Sep 2019.
Frequently asked questions
Adlac Life Science is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2007 (19+ years old) and is registered under CIN U24232GJ2007PTC051082.
Adlac Life Science has 2 current directors:
- Rupesh Dipakbhai Shah - Director
- Meet Rupeshbhai Shah - Director
The latest financial statements of Adlac Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Adlac Life Science is 24AAGCA4913R1ZD, registered in Gujarat.
The CIN (Corporate Identification Number) of Adlac Life Science is U24232GJ2007PTC051082. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adlac Life Science was incorporated on 11 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Adlac Life Science by revenue are Glynis Pharmaceutical Private Limited, MP Laboratories Private Limited, Medo Specia Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Meet Rupeshbhai Shah ceased to be Additional Director on 25 Sep 2019. Ravi Rasikbhai Shah ceased to be Director on 19 Oct 2018. Meet Rupeshbhai Shah was appointed as Director on 17 Oct 2018. Adlac Life Science has 5 board changes on record in total.
The registered office of Adlac Life Science is at 817 Kothari Industrial Estate, Kothari Cross Road, Kalol, Gujarat, India – 382721.
Adlac Life Science operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Adlac Life Science is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
